Inactive Instrument

All News Hansa Biopharma AB Nasdaq Stockholm

Equities

Real-time Estimate Cboe Europe Other stock markets 02:24:00 15/05/2024 pm IST			5-day change	1st Jan Change
37.57 ^SEK	-76.99%		-5.78%	-38.73%

18/04	Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024
18/04	Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Correction, Hansa Biopharma, increase in number of shares and votes	06/05	AQ
Correction: Hansa Biopharma: increase in number of shares and votes	03/05	PU
Hansa Biopharma: increase in number of shares and votes	03/05	AQ
Hansa Biopharma Q1 - Improved European launch support	19/04	AQ
Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024	18/04
Hansa Biopharma interim report January-March 2024	18/04	AQ
Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	18/04	CI
Hansa Biopharma Approves SEK372 Million Directed Share Issue	12/04	MT
Hansa Biopharma Announces Successful Execution of a Directed Share Issue of SEK 372 million (~USD 34.6 million)	12/04	AQ
Hansa Biopharma AB Provides Preliminary Unaudited Revenue Guidance for the First Quarter Ending March 31, 2024	02/04	CI
Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance	02/04	AQ
Hansa Biopharma publishes 2023 Annual and Sustainability Reports	21/03	AQ
Hansa Biopharma Hires New CFO	22/02	MT
Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer	22/02	AQ
Hansa Biopharma AB Announces CFO Changes	22/02	CI
Hansa Biopharma - Improved sales prospects	05/02	AQ
Transcript : Hansa Biopharma AB, Q4 2023 Earnings Call, Feb 02, 2024	02/02
Hansa Biopharma Year-end report January-December 2023	02/02	AQ
Hansa Biopharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02/02	CI
Hansa Biopharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	02/02	CI

No results for this search